JG
Insider
Jonathan Goldman
DirectorJonathan Goldman (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Avalo Therapeutics, Inc. (AVTX). The largest single filing was $118K of AVTX (8,200 sh × $14.35, as filed), executed Nov 14 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$118K
shares × price, as filed
Last traded
Nov 14 2025
Filed Nov 17 2025
Median ADV $28.3M across their filed names
Open performance→Volume by month
Buys $0
Sells $118K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
AVTXRecent filings
AVTXSALE
Avalo Therapeutics, Inc.
View filing →
$118K8,200 sh × $14.35
Exec Nov 14 2025
Filed Nov 17 2025 · 5:30 PM ET